↓ Skip to main content

Cochrane Database of Systematic Reviews

First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension

Overview of attention for article published in Cochrane database of systematic reviews, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

policy
1 policy source
twitter
29 X users
facebook
2 Facebook pages
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
312 Mendeley
Title
First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension
Published in
Cochrane database of systematic reviews, November 2018
DOI 10.1002/14651858.cd008170.pub3
Pubmed ID
Authors

Yu Jie Chen, Liang Jin Li, Wen Lu Tang, Jia Yang Song, Ru Qiu, Qian Li, Hao Xue, James M Wright

X Demographics

X Demographics

The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 312 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 312 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 38 12%
Student > Master 27 9%
Researcher 24 8%
Student > Ph. D. Student 21 7%
Other 18 6%
Other 53 17%
Unknown 131 42%
Readers by discipline Count As %
Medicine and Dentistry 84 27%
Nursing and Health Professions 26 8%
Pharmacology, Toxicology and Pharmaceutical Science 12 4%
Social Sciences 11 4%
Biochemistry, Genetics and Molecular Biology 6 2%
Other 34 11%
Unknown 139 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2023.
All research outputs
#1,718,005
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#3,699
of 13,156 outputs
Outputs of similar age
#35,057
of 355,347 outputs
Outputs of similar age from Cochrane database of systematic reviews
#95
of 243 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,347 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 243 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.